Weighted Average Number of Shares Outstanding, Basic of Aquestive Therapeutics, Inc. from Q2 2018 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2018 to Q3 2025.
  • Aquestive Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 111M shares, a 21.4% increase year-over-year.
  • Aquestive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 86.7M shares, a 41.6% increase from 2023.
  • Aquestive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 61.3M shares, a 25.7% increase from 2022.
  • Aquestive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 48.7M shares, a 28% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Aquestive Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 111M +19.5M +21.4% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 99.3M +8.42M +9.26% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 95.5M +21.9M +29.7% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 86.7M +25.5M +41.6% 01 Oct 2024 31 Dec 2024 10-K 05 Mar 2025
Q3 2024 91.1M +26.4M +40.8% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 90.9M +33.6M +58.5% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 73.6M +18M +32.3% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q4 2023 61.3M +12.5M +25.7% 01 Oct 2023 31 Dec 2023 10-K 05 Mar 2025
Q3 2023 64.7M +11.3M +21.1% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024
Q2 2023 57.4M +11.9M +26.2% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 55.6M +14.2M +34.2% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 48.7M +10.7M +28% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 53.4M +14.2M +36.2% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 45.5M +8.4M +22.7% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 41.5M +5.9M +16.6% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023
Q4 2021 38.1M 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 39.2M +5.61M +16.7% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022
Q2 2021 37.1M 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022
Q1 2021 35.6M +1.99M +5.94% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q3 2020 33.6M +8.59M +34.3% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021
Q1 2020 33.6M 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q3 2019 25M +1.39M +5.86% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 25M +5.79M +30.2% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2019
Q3 2018 23.6M 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019
Q2 2018 19.2M 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019

Aquestive Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 86.7M +25.5M +41.6% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2025
2023 61.3M +12.5M +25.7% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2025
2022 48.7M +10.7M +28% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 38.1M +4.43M +13.2% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 33.7M 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.